Anti-NS1 IgG3 Detection for Flavivirus Infections
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting Flavivirus infections, particularly dengue virus, face challenges such as high costs, short detection windows, and cross-reactivity among flaviviruses, making it difficult to distinguish recent infections from prior infections and vaccine-induced responses.
Innovation Solution
The use of anti-NS1 IgG3 antibodies measured in biological samples to detect recent Flavivirus infections, employing immunoassays like ELISAs, ELIspot, RIA, and Western blotting to differentiate between recent and long-term infections, and assess vaccine efficacy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional serology methods (IgM and total IgG detection) are used to detect Flavivirus infections, then the detection method is widely available and can identify infections, but the method suffers from high cross-reactivity among different flaviviruses and cannot distinguish recent infections from prior infections or vaccine-induced responses
Solution Approach 1:
The invention segments the IgG antibody response into four distinct subclasses (IgG1, IgG2, IgG3, IgG4) and analyzes their individual kinetic patterns. By measuring each subclass separately rather than total IgG, the method can distinguish between recent acute infections (characterized by specific subclass patterns) and past infections or vaccine responses (characterized by different patterns), thereby resolving the cross-reactivity problem while maintaining detection versatility
Solution Approach 2:
The invention changes the measurement parameter from total IgG or IgM levels to the specific ratio and absolute levels of IgG subclasses. This parameter transformation enables differentiation of infection timing and type, as each subclass exhibits distinct kinetic behavior during primary vs. secondary infections and during natural infection vs. vaccine response, thus improving measurement precision without sacrificing adaptability
2Measurement precision
If direct virus isolation or RNA detection methods are used, then the detection window is short and costs are high, but the method can provide definitive diagnosis of active infection
Solution Approach 1:
The invention measures IgG subclass levels that are produced early in the infection course and persist longer than viral RNA or antigen. By detecting these pre-existing antibody markers that remain detectable after the acute viral phase, the method extends the detection window beyond the short period when virus isolation or RNA detection is feasible, while maintaining diagnostic accuracy through the specific kinetic patterns of the subclasses
3Ease of manufacture
If total IgG levels are measured to assess immune response, then the method is simple and cost-effective, but it cannot distinguish between recent infections and long-term immunity or vaccine responses
Solution Approach 1:
The invention divides total IgG into four measurable subclasses (IgG1, IgG2, IgG3, IgG4) that can be detected using standard immunoassay platforms. This segmentation preserves the simplicity of ELISA-based methods while extracting additional diagnostic information, as the relative levels and kinetic patterns of each subclass provide temporal and etiological context that total IgG measurement alone cannot provide
Solution Approach 2:
The invention uses universal immunoassay platforms (ELISA, ELISPOT, RIA, Western blotting) that can detect multiple IgG subclasses simultaneously or sequentially using subclass-specific antibodies. This multi-functional approach maintains the ease and accessibility of conventional assays while enabling differentiation of infection timing and type through the distinct kinetic profiles of each subclass
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach provides a cost-effective and sensitive method for detecting recent Flavivirus infections, distinguishing between recent and past infections, and evaluating vaccine efficacy, with a wider detection window and reduced cross-reactivity.
Implementation Method 1
The use of anti-NS1 IgG3 antibodies measured in biological samples to detect recent Flavivirus infections, employing immunoassays like ELISAs, ELIspot, RIA, and Western blotting
Data Source
AI summary
Disclosed are compositions and methods for the detection of a Flavivirus infection. In some embodiments, the method comprises detecting a recent Flavivirus infection by measuring the amount of anti-NS1 IgG3. In other embodiments, the method comprises detecting a prior Dengue virus infection in a subject previously immunized with a Dengue virus vaccine comprising one or more non-Dengue Flavivirus proteins.